Circum-psoas block versus supra-inguinal fascia iliaca block in hip arthroplasty: a randomized controlled study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053421

Enrollment

Unknown

Registered

2021-11-20

Start date

2021-12-31

Completion date

Unknown

Last updated

2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

crico-psoas block group:ultrasound-guided circum-psoas block

Inguinal ligament suprafascia iliaca block group:supra-inguinal fascia iliaca block

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. SA I-III level; Aged 18-90 years; 2. BMI 18-30kg/m^2; 3. Elective hip replacement surgery; 4. Liver and kidney function are normal; 5. Patients were aware of this study and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Puncture point infection; 2. Anticoagulation state; 3. Allergy to local anesthetics; 4. Serious cardiovascular disease, blood disease; 5. Long-term use of opioids or alcohol abuse; 6. Combined with myasthenia gravis or Parkinson's disease or pregnancy status; 7. History of previous hip or spine surgery; 8. Cognitive dysfunction before surgery, unable to cooperate with pain assessment; 9. Narrowing of the space between the sacral wing and the transverse process of L5.

Design outcomes

Primary

Measure	Time frame
dynamic pain scores;	—

Secondary

Measure	Time frame
static pain scores;dynamic pain scores at 12, 24 and 48 hours after surgery;sensory block;motor block;first opioid request;duration of surgery;length of hospital stay;patient satisfaction;adverse events (vascular puncture, nerve injury, local anesthetic toxicity, dizziness, nausea, vomiting, urinary retention, respiratory depression);opioid consumption at 24 h and 48 h after surgery;	—

Countries

China

Contacts

Public ContactWang Yun

Beijing Chaoyang Hospital, Capital Medical Universit

wangyun129@ccmu.edu.cn+86 13521611825

Outcome results